Patents by Inventor Erick Lebrun

Erick Lebrun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel Systems, Methods, And Compositions For The Glycosylation Of Cannabinoid Compounds
    Publication number: 20250361537
    Abstract: The present invention relates generally to the identification novel UDP-glucosyltransferases enzymes having specific activity towards cannabinoid compounds. The present invention further relates generally to the use of novel UGT enzymes having specific activity towards cannabinoid compounds to generate water-soluble cannabinoid glycoside compounds.
    Type: Application
    Filed: August 5, 2025
    Publication date: November 27, 2025
    Inventors: Timothy Travers, Erick LeBrun
  • Systems, methods, and compositions for the glycosylation of cannabinoid compounds
    Patent number: 12378586
    Abstract: The present invention relates generally to the identification novel UDP-glucosyltransferases enzymes having specific activity towards cannabinoid compounds. The present invention further relates generally to the use of novel UGT enzymes having specific activity towards cannabinoid compounds to generate water-soluble cannabinoid glycoside compounds.
    Type: Grant
    Filed: February 26, 2021
    Date of Patent: August 5, 2025
    Assignee: Trait Biosciences, Inc.
    Inventors: Timothy Travers, Erick LeBrun
  • SYSTEMS, METHODS AND COMPOSITION OF USING RNASE III MUTANTS TO PRODUCE SRNA TO CONTROL HOST PATHOGEN INFECTION
    Publication number: 20230354822
    Abstract: The current invention includes systems, methods and compositions for the generation of sRNA molecules using select RNase III mutants. In one preferred embodiment, invention includes systems, methods and compositions for the generation of sRNA molecules using RNase III mutants to control a host pathogen through the production and diffusion of sRNA molecules that may initiate an RNAi pathway response directed to a host pathogen. Additional embodiments of the current invention include systems, methods and compositions for the DICER-independent generation of sRNA molecules using select RNase III mutants.
    Type: Application
    Filed: April 12, 2023
    Publication date: November 9, 2023
    Inventors: Guohua Yin, Erick Lebrun, Timothy Travers
  • Novel Systems, Methods, And Compositions For The Glycosylation Of Cannabinoid Compounds
    Publication number: 20230212625
    Abstract: The present invention relates generally to the identification novel UDP-glucosyltransferases enzymes having specific activity towards cannabinoid compounds. The present invention further relates generally to the use of novel UGT enzymes having specific activity towards cannabinoid compounds to generate water-soluble cannabinoid glycoside compounds.
    Type: Application
    Filed: February 26, 2021
    Publication date: July 6, 2023
    Inventors: Timothy Travers, Erick LeBrun
  • Compositions And Methods For Glycosylating Cannabinoid Compounds
    Publication number: 20220267820
    Abstract: The present invention relates generally to the use of novel UDP-glucosyltransferases enzymes having specific activity towards cannabinoid compounds. The present invention further relates generally to the use of novel UGT enzymes having specific activity towards cannabinoid compounds to generate water-soluble cannabinoid glycoside compounds.
    Type: Application
    Filed: March 1, 2021
    Publication date: August 25, 2022
    Inventors: Richard T. Sayre, Elton Carvalho Goncalves, Tawanda Zidenga, Stephanie Willette, Timothy Travers, Erick Lebrun